{
      "creators": [
        {
          "name": {
            "honourific": null,
            "family": "Kudratova Nozanin",
            "given": "Kudratova Nozanin",
            "lineage": null
          }
        }
      ],
      "uri": "https://arxiv.universalpublishings.com/id/eprint/100618",
      "abstract": " Ushbu tezisda onkologiyada inqilobiy o\u2018zgarishlarni amalga oshirgan rak immunoterapiyasining zamonaviy yo\u2018nalishlari va yutuqlari tahli qilinadi. Immunoterapiya \u2013 bu bemorning o\u2018z immunitet tizimini faollashtirish yoki kuchaytirish orqali saraton hujayralarini tanib olish va yo\u2018q qilish qobiliyatini tiklovchi davolash usulidir. Tezisda ushbu usullarning kimyoterapiya va radiologik davoga nisbatan afzalliklari (uzoq muddatli javob, yon ta'sirlarning nisbatan kamligi), shuningdek, hozirgi cheklovlari (yuqori narx, hamma bemorlarda samara bermaslik, og\u2018ir autoimmun yon ta'sirlar) ko\u2018rib chiqiladi. Xulosa qilib, immunoterapiya saraton davolashda yangi davrni ochgan bo\u2018lsa-da, uning samaradorligini oshirish va yon ta'sirlarni kamaytirish uchun kombinatsiyalashgan yondashuvlar (kimyoterapiya, nishonli terapiya bilan birga) va yangi nishonlarni izlash bo\u2018yicha tadqiqotlar davom etmoqda.",
      "dir": "disk0/00/10/06/18",
      "pagerange": "270-275",
      "lastmod": "2026-06-19 08:25:13",
      "official_url": "https://universalpublishings.com/index.php/itfttdm/article/view/15652",
      "publication": "\"XXI ASRDA INNOVATSION TEXNOLOGIYALAR, FAN VA TA\u02bcLIM TARAQQIYOTIDAGI DOLZARB MUAMMOLAR\" nomli respublika ilmiy-amaliy konferensiyasi",
      "metadata_visibility": "show",
      "eprint_status": "archive",
      "status_changed": "2026-06-19 08:25:13",
      "volume": 3,
      "full_text_status": "public",
      "number": 12,
      "type": "article",
      "documents": [
          {
            "files": [
                {
                  "mtime": "2026-06-19 08:25:13",
                  "hash_type": "MD5",
                  "filesize": 255699,
                  "objectid": 22232,
                  "mime_type": "application/pdf",
                  "filename": "Kudratova_N_270-275_XXI.pdf",
                  "uri": "https://arxiv.universalpublishings.com/id/file/160016",
                  "datasetid": "document",
                  "hash": "a6799a771de18bd10cde23fb73495a34",
                  "fileid": 160016
                }
            ],
            "format": "application/pdf",
            "main": "Kudratova_N_270-275_XXI.pdf",
            "language": "en",
            "eprintid": 100618,
            "placement": 1,
            "content": "published",
            "security": "public",
            "rev_number": 2,
            "docid": 22232,
            "pos": 1,
            "uri": "https://arxiv.universalpublishings.com/id/document/22232"
          }
      ],
      "ispublished": "pub",
      "rev_number": 3,
      "title": "RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR",
      "keywords": "rak immunoterapiyasi, immunnazorat nuqtalari, PD-1, PD-L1, CTLA-4, CAR-T terapiya, adoptiv hujayraviy terapiya, monoklonal antitelolar, saraton vaksinalari, titroq bo\u2018shliq, personalizatsiyalangan onkologiya",
      "date": "2025-12-22",
      "datestamp": "2026-06-19 08:25:13",
      "eprintid": 100618
    }